Inactive Instrument

HEAR CATA Stock

HCAQ

KYG441251058

HealthCor Catalio Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It intends to focus its search in the healthcare industry. It is neither engaged in any operations nor generates any revenues.

Employees

Sector

More about the company

21-12-22	Hyperfine Completes Merger With HealthCor Catalio Acquisition, Liminal Sciences	MT
21-12-22	HealthCor Catalio Acquisition Corp.(NasdaqCM:HCAQ) dropped from NASDAQ Composite Index	CI
21-12-21	Hyperfine, Inc. and Liminal Sciences, Inc. completed the acquisition of HealthCor Catalio Acquisition Corp. from HC Sponsor LLC and others in a reverse merger transaction.	CI
21-08-13	HealthCor Catalio Acquisition Corp Announces Executive Changes	CI
21-08-13	HealthCor Catalio Acquisition Corp. Announces Board Changes	CI
21-07-24	Certain Class B Ordinary Shares of HealthCor Catalio Acquisition Corp. are subject to a Lock-Up Agreement Ending on 25-JUL-2021.	CI
21-07-08	HealthCor Catalio Acquisition : Hyperfine to Merge With Blank Check Firm HealthCor Catalio Acquisition, List on Nasdaq	MT
21-07-07	Hyperfine, Inc. and Liminal Sciences, Inc. entered into a definitive business combination agreement to acquire HealthCor Catalio Acquisition Corp. from HC Sponsor LLC and others for approximately $650 million in a reverse merger transaction.	CI
21-01-29	HEAR CATA : HealthCor Catalio Acquisition Raises Gross Proceeds of $207 Million in IPO	MT
21-01-28	HealthCor Catalio Acquisition Corp. announced that it has received $6.14 million in funding from HC Sponsor LLC	CI
21-01-28	HealthCor Catalio Acquisition Corp.(NasdaqCM:HCAQ) added to NASDAQ Composite Index	CI
21-01-27	HEAR CATA : HealthCor Catalio Acquisition Prices $180 Million IPO	MT
21-01-26	HealthCor Catalio Acquisition Corp. has completed an IPO in the amount of $180 million.	CI

21-12-28	HEAR CATA : UNAUDITED PRO FORMA CONDENSED COMBINED FINANCIAL INFORMATION - Form 8-K	PU
21-12-22	Hyperfine Closes Business Combination with HealthCor Catalio Acquisition Corp and Liminal Sciences, Will Begin Trading under the Ticker "HYPR" on the Nasdaq Global Market	PR
21-12-22	HealthCor Catalio Acquisition : Submission of Matters to a Vote of Security Holders - Form 8-K	PU
21-12-22	HEALTHCOR CATALIO ACQUISITION CORP. : Submission of Matters to a Vote of Security Holders, Other Events (form 8-K)	AQ
21-12-15	HealthCor Catalio Acquisition Corp. Reminds Shareholders to Vote in Favor of the Business Combination with Hyperfine, Inc. and Liminal Sciences, Inc.	PR

Date	Insider	Type	Main position	Quantity	% Market Cap.
21-12-21	Joe Healey	Conversion	Chairman	4,920,000	95.0725%
21-01-25	Christopher Wolfgang	Other	Director	35,000	0.9333%
21-01-25	Michael Weinstein	Other	Director	35,000	0.9333%

HEAR CATA Stock

Stocks

HCAQ

KYG441251058

Latest news : HEAR CATA

Press Releases: HEAR CATA

Quotes and Performance

Latest insider transactions

Company Profile